Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental - Archive ouverte HAL Access content directly
Journal Articles BMC Psychiatry Year : 2019

Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental

(1) , (2) , (3) , , , , , (4) , (4) , (5) , (6) , (7) , (6) , , (8) , (6) , (9) , , (10) , (11) , (3) , , (12) , , (4) , (5) , (4) , (13) , (6) , (14)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
J.-B. Genty
  • Function : Author
S. Destouches
  • Function : Author
S. Lancrenon
  • Function : Author
N. Alaïli
  • Function : Author
V. Camus
  • Function : Author
J. Holtzmann
  • Function : Author
I. Nieto
  • Function : Author
F. Stephan
  • Function : Author
M. Walter
  • Function : Author
Wissam El-Hage

Abstract

Background: Clear guidance for successive antidepressant pharmacological treatments for non-responders in major depression is not well established. Method: Based on the RAND/UCLA Appropriateness Method, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental developed expert consensus guidelines for the management of treatment-resistant depression. The expert guidelines combine scientific evidence and expert clinicians’ opinions to produce recommendations for treatment-resistant depression. A written survey comprising 118 questions related to highly-detailed clinical presentations was completed on a risk-benefit scale ranging from 0 to 9 by 36 psychiatrist experts in the field of major depression and its treatments. Key-recommendations are provided by the scientific committee after data analysis and interpretation of the results of the survey. Results: The scope of these guidelines encompasses the assessment of pharmacological resistance and situations at risk of resistance, as well as the pharmacological and psychological strategies in major depression. Conclusion: The expert consensus guidelines will contribute to facilitate treatment decisions for clinicians involved in the daily assessment and management of treatment-resistant depression across a number of common and complex clinical situations.
Fichier principal
Vignette du fichier
2019_Bennabi_BMC_Psychiatry.pdf (880.36 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

hal-02524109 , version 1 (30-03-2020)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

D. Bennabi, T. Charpeaud, A. Yrondi, J.-B. Genty, S. Destouches, et al.. Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental. BMC Psychiatry, 2019, 19 (1), pp.262. ⟨10.1186/s12888-019-2237-x⟩. ⟨hal-02524109⟩
94 View
157 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More